MorphoSys AG (MOR.DE)

XETRA - XETRA Delayed Price. Currency in EUR

Add to watchlist

23.12

+0.66

(+2.94%)

As of 03:50PM CEST. Market open.

Advertisement

Full screen

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	22.46
Open	22.40
Bid	23.06 x 1500
Ask	23.13 x 8800
Day's Range	21.91 - 23.14
52 Week Range	16.45 - 51.60
Volume	70,639
Avg. Volume	164,024

Market Cap	791.442M
Beta (5Y Monthly)	0.92
PE Ratio (TTM)	N/A
EPS (TTM)	-17.65
Earnings Date	Aug 03, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	38.50

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for MOR.DE

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

All

News

Press Releases

Motley Fool
MorphoSys AG (MOR) Q2 2022 Earnings Call Transcript
At this time, I would like to turn the conference over to Julia Neugebauer. My name is Julia Neugebauer, head of investor relations at MorphoSys, and it is my pleasure to welcome you to our half year 2022 financial results conference call. With me on the call today are Jean-Paul Kress, chief executive officer; Sung Lee, chief financial officer; Malte Peters, chief research and development officer; and Joe Horvat, U.S. general manager.
Business Wire
MorphoSys AG Reports Second Quarter and First Half 2022 Financial Results
PLANEGG/MUNICH, Germany, August 03, 2022--Conference call and webcast (in English) tomorrow, August 4, 2022, at 2:00pm CEST (1pm BST/8:00am EDT)
- Kubient Sets Second Quarter 2022 Earnings Call for Monday, August 15, 2022 at 4:30 p.m. ET
  GlobeNewswire
- Elanco Animal Health Reports Second Quarter 2022 Results
  Business Wire
ACCESSWIRE
MorphoSys AG: Invitation to MorphoSys' Second Quarter and First Half Year 2022 Results Conference Call on August 4 , 2022
MorphoSys AG (FSE:MOR); (NASDAQ:MOR) will publish its results for the second quarter and first half year 2022 results on August 3, 2022 at 10:00 pm CEST (9:00 pm BST; 4:00 pm EDT). MorphoSys' Management team will host a conference call and webcast on August 4, 2022 at 2:00 pm CEST (1:00 pm BST; 8:00 am EDT) to present the second quarter and first half year financial results 2022 and provide an outlook for 2022.